Biomarker Labs Pitch Deck: Slide-by-Slide Breakdown

The Vision: Quantifying Wellness

Biomarker Labs entered the market in 2016 with a clear, if ambitious, goal: to become the data layer for the fragmented wellness industry. At the time of this deck, the 'quantified self' movement was hitting its stride, with wearables becoming mainstream and consumer lab testing gaining traction. This deck attempts to position Biomarker Labs not just as another app, but as the analytical engine that proves whether the $3.7 trillion spent on wellness actually yields results.

Slides 1-2: The Hook and the Human Element

Slide 1 is a standard title slide featuring the company logo and the tagline: "Connecting The Dots In Health & Nutrition." The visual theme of interconnected nodes establishes the company's identity as a data aggregator from the outset.

Slide 2 introduces 'Karen,' a persona representing the confused consumer. The slide asks, "How do you get healthy?" and lists Physical, Mental, and Social health, ending with a large red question mark and the phrase "Where to Start?" This is a classic 'Problem' slide, though it leans more on emotional confusion than specific market pain points. It sets the stage for a solution that provides direction in an oversaturated market.

Slides 3-4: Market Size and Conceptual Framework

Slide 3 hits the investor with a massive number: "A $3.7 Trillion Industry Dedicated to Health & Wellness." To ground this staggering figure, the slide includes a collage of logos ranging from Apple Watch and Fitbit to Equinox and 23andMe. This demonstrates that Biomarker Labs isn't competing with these giants; it is positioning itself to sit on top of them. The footnote cites the Global Wellness Institute as the source for this data.

Slide 4 , titled "Simplifying the Industry," uses a flow chart to explain their logic. It moves from the broad "Health & Wellness Industry" to "Products & Services," and finally to "Inputs." This is the core of their thesis: everything a consumer buys for their health should be treated as a data input for a larger system.

Slides 5-6: The Solution and Data Sources

Slide 5 introduces the product interface via a desktop mockup. It explains the process of "Measuring Health & Wellness Offerings." The diagram shows Inputs (Products and Services) going into the Biomarker platform and resulting in Outputs (Product Impact and Services Impact). This slide is crucial because it defines the company's role as the validator of efficacy.

Slide 6 is perhaps the most important slide for technical due diligence. Titled "Leveraging Digital Health," it categorizes their data sources into three buckets: Hardware (Apple Watch, Fitbit, Garmin, etc.), Software (MyFitnessPal, Sony, Samsung), and Labs & Blood Panels (LabCorp, Quest, 23andMe). By listing these logos, Biomarker Labs signals that they are building a platform capable of ingesting diverse data sets to create a unified health score.

Slides 7-8: The Dual-Sided Value Proposition

Slide 7 focuses on the consumer ("Customers"). The value prop is distilled into three words: Connect, Track, Discover . The accompanying mockup shows a 'spider chart' or radar plot, which is a common way to visualize multi-factor health data. This suggests a sophisticated user experience that goes beyond simple step-counting.

Slide 8 pivots to the B2B side ("Companies"). Here, the value proposition is Validate Offerings, Targeted Sales, and Increase Retention . This is where the revenue model likely lives. By providing brands with an 'Admin Dashboard' (shown in the mockup), Biomarker Labs allows supplement and nutrition companies to see how their products are performing across their user base, providing a powerful tool for R&D and marketing.

Slides 9-11: Team, Market Focus, and Traction

Slide 9 presents the team. Led by Garrett T. Ruhland (CEO) and Bryan M. Welker (COO), the six-person team includes an MD/Biomedical Engineer and three engineers. The logos on the right—Duke, Stanford, Google, NIH, IBM—provide significant 'social proof,' suggesting the founders have the pedigree to execute in a highly regulated and technical space.

Slide 10 is a significant failure in the deck's production. Titled "Targeting the Supplement Industry First," it features three red circles that presumably contain key market statistics. However, the text inside the circles is white on a white background, making it completely illegible. In a professional pitch environment, this is a major oversight that obscures the rationale for their go-to-market strategy.

Slide 11 concludes the deck with "Early Traction." The numbers are respectable for a Seed stage startup in 2016: 4 Customers , $20K MRR , and a $2M Pipeline . These figures suggest that at least four companies were already paying $5,000 per month on average to access Biomarker's validation data, proving the B2B model has legs.

What Works in This Deck

The deck excels at positioning . By framing the wellness industry as a collection of 'inputs' that require 'validation,' Biomarker Labs carves out a niche that doesn't require them to fight Apple or Fitbit. Instead, they become a necessary partner for the thousands of supplement and nutrition brands that lack their own data infrastructure. The traction slide is also a high point; $20K MRR with only 4 customers indicates a high-value enterprise sale rather than a low-cost consumer subscription, which is often more attractive to Seed investors.

What is Missing

The most glaring omission is The Ask . There is no slide detailing how much money they are raising, what the valuation is, or what the milestones are for the next 18 months. Furthermore, the Competitive Landscape is missing. While they show who they integrate with, they don't show who they compete against (e.g., InsideTracker or other wellness analytics platforms). Finally, the Unit Economics are absent. We see the MRR, but we don't know the cost of acquiring those four customers or the churn rate of the end consumers using the app.

What a Founder Should Copy

Founders should emulate the clear categorization of data sources found on Slide 6. If your startup relies on integrations, showing the logos of the ecosystem you inhabit helps investors immediately understand your place in the 'stack.' Additionally, the dual-sided value proposition (Slides 7 and 8) is a great way to show how a single product serves two different masters—the user and the payer. This clarity is essential for B2B2C models. Lastly, the use of clean, high-fidelity mockups on slides 5, 7, and 8 gives the impression of a product that is already built and functional, which reduces perceived execution risk.

Final Thoughts

Biomarker Labs presents a compelling case for the 'Data-fication' of wellness. Despite a technical glitch on the market focus slide and a missing 'Ask,' the combination of a high-pedigree team and solid early revenue makes this a strong Seed-stage deck. It successfully moves the conversation from 'wellness is a hobby' to 'wellness is a measurable clinical outcome,' which is exactly the shift needed to capture venture capital interest in the health-tech space.